![]() ![]() Determine and address possible reporting clusters ( e.g., suspected localized or product-/batch-/lot-specific adverse event reporting).Assess the safety of newly licensed vaccines.Identify potential patient risk factors for particular types of adverse events.Monitor increases in known adverse events.Detect new, unusual, or rare vaccine adverse events.To further assess a possible safety concern. This way, VAERS can provide CDC and FDA with valuable information that additional work and evaluation is necessary Unusual or unexpected patterns of adverse event reporting that might indicate a possible safety problem with a vaccine. VAERS is not designed to determine if a vaccine caused a health problem, but is especially useful for detecting VAERS is a passive reporting system, meaning it relies on individuals to send in reports of their experiences to CDC and FDA. Professionals are required to report certain adverse events and vaccine manufacturers are required to report all adverse events that come to their attention. Anyone can report an adverse event to VAERS. VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination. ![]() VAERS is co-managed by the Centers for Disease Control and Prevention About VAERS Background and Public Health ImportanceĮstablished in 1990, the Vaccine Adverse Event Reporting System (VAERS) is a national early warning system to detect possible safety problems in U.S.-licensed vaccines. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |